Results 221 to 230 of about 294,750 (308)

PNP11: DIABETES MELLITUS AND OTHER CARDIOVASCULAR RISK FACTORS IN PATIENTS RECEIVING ANTIDEPRESSANT DRUGS

, 1999
A. Thomas Taylor, M. Sajjad Athar, P. Wagner, Ali Ahmed   +3 more
openalex   +1 more source

Quality of Life in Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare disorder of the nervous system that detrimentally influences health‐related quality of life (HRQoL). Evidence regarding factors influencing HRQoL in CIDP is scarce.
Tobias C. Blum, Hendrik van der Wurp, David Mengel, Linda Fraune, Norbert Sommer, Mark Stettner, Björn Tackenberg, Richard Dodel   +7 more
wiley   +1 more source

The Impact of Depression and Antidepressant Treatment on Patient-Reported Outcomes Following Thumb Carpometacarpal Arthroplasty. [PDF]

J Hand Surg Glob Online
Mohamed OM, Duggan JL, Hines KE, Harper CM, Rozental TD, Shoji MM.   +5 more
europepmc   +1 more source

Factors Impacting Tracheostomy Decisions in Korean Individuals With Amyotrophic Lateral Sclerosis: A Cross‐Sectional Survey

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Decisions regarding tracheostomy are often made under emergent circumstances, although they require complex considerations of patient preferences, quality of life, and prognosis. This study investigated decision‐making surrounding tracheostomy in Korean people with amyotrophic lateral sclerosis (pwALS) and factors influencing
Juhee Chae, Shin Hye Yoo, Sun Young Lee, Jong‐Su Kim, Jung‐Joon Sung, Seok‐Jin Choi   +5 more
wiley   +1 more source

Correction to "Discovery of a Novel and Potent Kir4.1 Inhibitor as a Safe and Rapid-Onset Antidepressant Agent in Mice". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

Treatment for Comorbid Mental Health Disorders Among Patients Treated for Opioid Disorder: The Role of a Hub and Spoke Intervention. [PDF]

Community Ment Health J
Hodgkin D, Daily SM, Panas L, Ritter G, Stewart MT, Reif S.   +5 more
europepmc   +1 more source

Does cannabis use require higher doses of anti-psychotic and antidepressant medications?

Tripdatabase
openalex   +1 more source

Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported.
Jalesh N. Panicker, Chris Harding, Hashim Hashim, Claire Hentzen, Nikita Bhatt, Arjun Nambiar, Brigitte Schurch, Mathijs de Rijk, Stefania Musco   +8 more
wiley   +1 more source

DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs. [PDF]

Front Psychiatry
Cheung N.
europepmc   +1 more source

What Role Does the Central Nervous System Play in Refractory LUTS, and What Are the Therapeutic Implications? ICI‐RS 2025

Neurourology and Urodynamics, EarlyView.
ABSTRACT Aims While many patients with lower urinary tract symptoms (LUTS) improve by treating peripheral causes, a substantial proportion continue to experience symptoms despite apparently successful interventions. Central nervous system (CNS) mechanisms could potentially contribute to persisting symptoms after the initial peripheral cause has been ...
Mathijs M. de Rijk, Michel Wyndaele, Ana Charrua, Christopher Fry, Paul Abrams, Gommert A. van Koeveringe, Anthony J. Kanai, Marcus J. Drake   +7 more
wiley   +1 more source